# Harvard Bioscience Inc: Form DEF 14A, filed Apr 3, 2024

- Company: [Harvard Bioscience Inc](/companies/hbio.md) (CIK 1123494)
- Form: DEF 14A
- Filed: 2024-04-03
- Accepted by EDGAR: Apr 3, 2024, 16:45 ET
- Period: 2024-05-14
- Accession: 0001171843-24-001813
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1123494/000117184324001813/def14a_040324.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1123494/000117184324001813/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1123494/000117184324001813/def14a_040324.htm

Filed Apr 3, 2024.
Source: SEC EDGAR, the filing index for accession 0001171843-24-001813. Last ingested by Listed: Nov 11, 2026, 01:53 ET. No prices; not investment advice.
